• Je něco špatně v tomto záznamu ?

Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL

D. Antic, N. Milic, T. Chatzikonstantinou, L. Scarfò, V. Otasevic, N. Rajovic, D. Allsup, A. Alonso Cabrero, M. Andres, M. Baile Gonzales, A. Capasso, R. Collado, R. Cordoba, C. Cuéllar-García, JG. Correa, L. De Paoli, MR. De Paolis, G. Del...

. 2022 ; 15 (1) : 116. [pub] 20220826

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, multicentrická studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc22024734

BACKGROUND: Patients with chronic lymphocytic leukemia (CLL) may be more susceptible to COVID-19 related poor outcomes, including thrombosis and death, due to the advanced age, the presence of comorbidities, and the disease and treatment-related immune deficiency. The aim of this study was to assess the risk of thrombosis and bleeding in patients with CLL affected by severe COVID-19. METHODS: This is a retrospective multicenter study conducted by ERIC, the European Research Initiative on CLL, including patients from 79 centers across 22 countries. Data collection was conducted between April and May 2021. The COVID-19 diagnosis was confirmed by the real-time polymerase chain reaction (RT-PCR) assay for SARS-CoV-2 on nasal or pharyngeal swabs. Severe cases of COVID-19 were defined by hospitalization and the need of oxygen or admission into ICU. Development and type of thrombotic events, presence and severity of bleeding complications were reported during treatment for COVID-19. Bleeding events were classified using ISTH definition. STROBE recommendations were used in order to enhance reporting. RESULTS: A total of 793 patients from 79 centers were included in the study with 593 being hospitalized (74.8%). Among these, 511 were defined as having severe COVID: 162 were admitted to the ICU while 349 received oxygen supplementation outside the ICU. Most patients (90.5%) were receiving thromboprophylaxis. During COVID-19 treatment, 11.1% developed a thromboembolic event, while 5.0% experienced bleeding. Thrombosis developed in 21.6% of patients who were not receiving thromboprophylaxis, in contrast to 10.6% of patients who were on thromboprophylaxis. Bleeding episodes were more frequent in patients receiving intermediate/therapeutic versus prophylactic doses of low-molecular-weight heparin (LWMH) (8.1% vs. 3.8%, respectively) and in elderly. In multivariate analysis, peak D-dimer level and C-reactive protein to albumin ratio were poor prognostic factors for thrombosis occurrence (OR = 1.022, 95%CI 1.007‒1.038 and OR = 1.025, 95%CI 1.001‒1.051, respectively), while thromboprophylaxis use was protective (OR = 0.199, 95%CI 0.061‒0.645). Age and LMWH intermediate/therapeutic dose administration were prognostic factors in multivariate model for bleeding (OR = 1.062, 95%CI 1.017-1.109 and OR = 2.438, 95%CI 1.023-5.813, respectively). CONCLUSIONS: Patients with CLL affected by severe COVID-19 are at a high risk of thrombosis if thromboprophylaxis is not used, but also at increased risk of bleeding under the LMWH intermediate/therapeutic dose administration.

1st Department of Medicine Hematology 1st Faculty of Medicine Charles University and General Hospital Prague Prague Czech Republic

1st Internal Medicine Department Propaedeutic Hematology Clinical Trial Unit National and Kapodistrian University of Athens Athens Greece

4th Department of Internal Medicine Haematology Faculty of Medicine in Hradec Králové University Hospital and Charles University Prague Hradec Kralove Czech Republic

Centre for Atherothrombosis and Metabolic Disease Hull York Medical School Hull UK

Clinical Centre of Vojvodina Faculty of Medicine University of Novi Sad Novi Sad Serbia

Clinical Hematology Unit Oncology Center Faculty of Medicine Mansoura University Mansoura 35516 Egypt

Consultant Haematologist St James's Hospital Leeds LS9 7TF UK

Consultative Hematology Department with a Day Hospital for Intensive High Dose Chemotherapy National Research Center for Hematology Moscow Russia

Department and Clinic of Hematology Blood Neoplasms and Bone Marrow Transplantation Wroclaw Medical University Pasteura Street 4 50 367 Wrocław Poland

Department Hematooncology and Bone Marrow Transplantation Medical University in Lublin Lublin Poland

Department Internal Medicine Maastricht University Medical Center Maastricht The Netherlands

Department of Biomedicine and Prevention Hematology University Tor Vergata Rome Italy

Department of Haematology Athens Medical Center Psychikon Branch Athens Greece

Department of Hematology and Central Hematology Laboratory Inselspital Bern University Hospital University of Bern Bern Switzerland

Department of Hematology Cancer Center Amsterdam Amsterdam University Medical Centers University of Amsterdam Amsterdam The Netherlands

Department of Hematology Gelderse Vallei Ede Ede The Netherlands

Department of Hematology Haga Teaching Hospital The Hague The Netherlands

Department of Hematology Health Research Institute IIS FJD Fundacion Jimenez Diaz University Hospital Madrid Spain

Department of Hematology Hospital del Mar Barcelona Spain

Department of Hematology Hospital General Universitario Valencia Spain

Department of Hematology Infanta Leonor University Hospital Madrid Spain

Department of Hematology Lymmcare Cancer Center Amsterdam Amsterdam University Medical Centers University of Amsterdam Amsterdam The Netherlands

Department of Hematology Shamir Medical Center Zerifin Israel

Department of Hematology Tel Aviv Sourasky Medical Center and Sackler School of Medicine Tel Aviv University Tel Aviv Israel

Department of Hematology Universitaire Ziekenhuizen Leuven Leuven Belgium

Department of Hematology University Hospital Dubrava Zagreb Croatia

Department of Internal Medicine Albert Schweitzer Hospital Dordrecht The Netherlands

Department of Internal Medicine Hematology and Oncology University Hospital Brno Czechia

Department of Internal Medicine Postgraduate Institute of Medical Education and Research Chandigarh India

Department of Internal Medicine Rijnstate Hospital Arnhem The Netherlands

Department of Medical Genetics and Genomics Faculty of Medicine Masaryk University Brno Czechia

Department of Medical Statistics and Informatics Faculty of Medicine University of Belgrade Belgrade Serbia

Department of Medicine and Surgery Institute of Hematology and Center for Hemato Oncological Research Ospedale S Maria della Misericordia Perugia Italy

Department of Medicine Ottawa Hospital Research Institute University of Ottawa Ottawa ON K1H 8L6 Canada

Department of Medicine Section of Hematology University of Verona Verona Italy

Dipartimento di Diagnostica per Immagini Radioterapia Oncologica ed Ematologia Fondazione Policlinico Universitario Agostino Gemelli IRCCS Rome Italy

Division of Hematology A O U Cittàdella Salute e della Scienza di Torino and Department of Molecular Biotechnology and Health Sciences University of Turin Turin Italy

Division of Hematology Fondazione IRCCS Policlinico San Matteo Pavia Italy

Division of Hematology Rabin Medical Center Petah Tikva and the Sackler School of Medicine Tel Aviv University Tel Aviv Israel

Division of Internal Medicine Hematology Unit ASL Vercelli Vercelli Italy

Experimental Hematooncology Department Medical University of Lublin Lublin Poland

Faculty of Medicine University of Belgrade Belgrade Serbia

Federal State Budgetary Educational Institution of Higher Education Academician 1 P Pavlov 1st St Petersburg State Medical University of the Ministry of Healthcare of Russian Federation St Petersburg Russia

Fundación de Investigación del Hospital General Universitario Valencia Spain

FUNDALEU Clinical Research Center Buenos Aires Buenos Aires Argentina

Haematology Department Hospital Universitario de La Princesa Madrid Spain

Hematology and Clinical Immunology Unit Department of Medicine University of Padova Padua Italy

Hematology and Stem Cell Transplant Center Marche Nord Hospital Pesaro Italy

Hematology and Stem Cell Transplantation Unit Ospedale Oncologico A Businco ARNAS G Brotzu Cagliari Italy

Hematology ASST Papa Giovanni XXIII Bergamo Italy

Hematology Center after Prof Yeolyan MH RA Yerevan Armenia

Hematology Clinic ASUFC Udine Italy

Hematology Department and HCT Unit G Papanicolaou Hospital Thessaloniki Greece

Hematology Department Colentina Clinical Hospital Bucharest Romania

Hematology Department from Coltea Clinical Hospital Carol Davila University of Medicine and Pharmacy Bucharest Romania

Hematology Department Hospital Universitario 12de Octubre Madrid Spain

Hematology Department Hospital Universitario Puerta de Hierro Majadahonda Madrid Spain

Hematology Department of Translational and Precision Medicine Sapienza University Rome Italy

Hematology Department Portuguese Institute of Oncology Lisbon Lisbon Portugal

Hematology Department Ramón y Cajal University Hospital Madrid Spain

Hematology Department St John's Cancer Center Lublin Poland

Hematology Department Unit Research Complejo Asistencial Universitario de Burgos Burgos Spain

Hematology Department University Hospital of Salamanca IBSAL Salamanca Spain

Hematology Fondazione IRCCS Istituto Nazionale Tumori Milan Italy

Hematology Section Department of Medical Oncology National Center for Cancer Care and Research Doha Qatar

Hematology Unit and TMO Center AO SS Antonio e Biagio e Cesare Arrigo Alessandria Italy

Hematology Unit AO Cosenza Cosenza Italy

Hematology Unit Azienda Unità Sanitaria Locale IRCCS Reggio Emilia Italy

Hematology Unit Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico of Milan Milan Italy

Hematology Unit Nepal Cancer Hospital and Research Center Lalitpur Nepal

Hematology Unit Terrassa Hospital Terrassa Spain

Hospital Clínic de Barcelona Barcelona Spain

Hospital Italiano La Plata La Plata Argentina

Institute of Applied Biosciences Centre for Research and Technology Hellas Thessaloniki Greece

IRCSS Ospedale San Raffaele Milan Italy

Laboratory for Leukemia Diagnostics Department of Medicine 3 University Hospital LMU Munich Munich Germany

Lymphoma Center Clinic for Hematology University Clinical Center of Serbia Belgrade Serbia

S C Ematologia ASST Spedali Civili Brescia Brescia Italy

Sackler Faculty of Medicine Tel Aviv University Tel Aviv Israel

SC Ematologia AO S Croce e Carle Cuneo Italy

Section of Hematology Department of Medical Sciences University of Modena and Reggio E Modena Italy

Sezione di Ematologia Dipartimento di Scienze Radiologiche ed Ematologiche Università Cattolica del Sacro Cuore Rome Italy

Spanish Society of Haematology and Hemotherapy Madrid Spain

St Anna University Hospital Ferrara Italy

Università Vita Salute San Raffaele and IRCC Ospedale San Raffaele Milan Italy

University Hospital and Research Institute of Marqués de Valdecilla Santander Spain

UOC Ematologia PO Vito Fazzi Lecce Lecce Italy

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22024734
003      
CZ-PrNML
005      
20221031100120.0
007      
ta
008      
221017s2022 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s13045-022-01333-0 $2 doi
035    __
$a (PubMed)36028857
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Antic, Darko $u Lymphoma Center, Clinic for Hematology, University Clinical Center of Serbia, Belgrade, Serbia. darko.antic1510976@gmail.com $u Faculty of Medicine, University of Belgrade, Belgrade, Serbia. darko.antic1510976@gmail.com
245    10
$a Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL / $c D. Antic, N. Milic, T. Chatzikonstantinou, L. Scarfò, V. Otasevic, N. Rajovic, D. Allsup, A. Alonso Cabrero, M. Andres, M. Baile Gonzales, A. Capasso, R. Collado, R. Cordoba, C. Cuéllar-García, JG. Correa, L. De Paoli, MR. De Paolis, G. Del Poeta, M. Dimou, M. Doubek, M. Efstathopoulou, S. El-Ashwah, A. Enrico, B. Espinet, L. Farina, A. Ferrari, M. Foglietta, A. Lopez-Garcia, JA. García-Marco, R. García-Serra, M. Gentile, E. Gimeno, MG. da Silva, O. Gutwein, YK. Hakobyan, Y. Herishanu, JÁ. Hernández-Rivas, T. Herold, G. Itchaki, O. Jaksic, A. Janssens, OB. Kalashnikova, E. Kalicińska, AP. Kater, S. Kersting, M. Koren-Michowitz, J. Labrador, D. Lad, L. Laurenti, A. Fresa, MD. Levin, C. Mayor Bastida, L. Malerba, R. Marasca, M. Marchetti, J. Marquet, B. Mihaljevic, I. Milosevic, F. Mirás, M. Morawska, M. Motta, T. Munir, R. Murru, R. Nunes, J. Olivieri, MA. Pavlovsky, I. Piskunova, VM. Popov, FM. Quaglia, G. Quaresmini, G. Reda, GM. Rigolin, A. Shrestha, M. Šimkovič, S. Smirnova, M. Špaček, P. Sportoletti, O. Stanca, N. Stavroyianni, D. Te Raa, K. Tomic, S. Tonino, L. Trentin, E. Van Der Spek, M. van Gelder, M. Varettoni, A. Visentin, C. Vitale, V. Vukovic, E. Wasik-Szczepanek, T. Wróbel, LYS. Segundo, M. Yassin, M. Coscia, A. Rambaldi, E. Montserrat, R. Foà, A. Cuneo, M. Carrier, P. Ghia, K. Stamatopoulos
520    9_
$a BACKGROUND: Patients with chronic lymphocytic leukemia (CLL) may be more susceptible to COVID-19 related poor outcomes, including thrombosis and death, due to the advanced age, the presence of comorbidities, and the disease and treatment-related immune deficiency. The aim of this study was to assess the risk of thrombosis and bleeding in patients with CLL affected by severe COVID-19. METHODS: This is a retrospective multicenter study conducted by ERIC, the European Research Initiative on CLL, including patients from 79 centers across 22 countries. Data collection was conducted between April and May 2021. The COVID-19 diagnosis was confirmed by the real-time polymerase chain reaction (RT-PCR) assay for SARS-CoV-2 on nasal or pharyngeal swabs. Severe cases of COVID-19 were defined by hospitalization and the need of oxygen or admission into ICU. Development and type of thrombotic events, presence and severity of bleeding complications were reported during treatment for COVID-19. Bleeding events were classified using ISTH definition. STROBE recommendations were used in order to enhance reporting. RESULTS: A total of 793 patients from 79 centers were included in the study with 593 being hospitalized (74.8%). Among these, 511 were defined as having severe COVID: 162 were admitted to the ICU while 349 received oxygen supplementation outside the ICU. Most patients (90.5%) were receiving thromboprophylaxis. During COVID-19 treatment, 11.1% developed a thromboembolic event, while 5.0% experienced bleeding. Thrombosis developed in 21.6% of patients who were not receiving thromboprophylaxis, in contrast to 10.6% of patients who were on thromboprophylaxis. Bleeding episodes were more frequent in patients receiving intermediate/therapeutic versus prophylactic doses of low-molecular-weight heparin (LWMH) (8.1% vs. 3.8%, respectively) and in elderly. In multivariate analysis, peak D-dimer level and C-reactive protein to albumin ratio were poor prognostic factors for thrombosis occurrence (OR = 1.022, 95%CI 1.007‒1.038 and OR = 1.025, 95%CI 1.001‒1.051, respectively), while thromboprophylaxis use was protective (OR = 0.199, 95%CI 0.061‒0.645). Age and LMWH intermediate/therapeutic dose administration were prognostic factors in multivariate model for bleeding (OR = 1.062, 95%CI 1.017-1.109 and OR = 2.438, 95%CI 1.023-5.813, respectively). CONCLUSIONS: Patients with CLL affected by severe COVID-19 are at a high risk of thrombosis if thromboprophylaxis is not used, but also at increased risk of bleeding under the LMWH intermediate/therapeutic dose administration.
650    _2
$a senioři $7 D000368
650    _2
$a antikoagulancia $7 D000925
650    12
$a COVID-19 $7 D000086382
650    _2
$a testování na COVID-19 $7 D000086742
650    _2
$a krvácení $7 D006470
650    _2
$a heparin nízkomolekulární $7 D006495
650    _2
$a lidé $7 D006801
650    12
$a chronická lymfatická leukemie $7 D015451
650    _2
$a SARS-CoV-2 $7 D000086402
650    12
$a trombóza $7 D013927
650    12
$a žilní tromboembolie $7 D054556
650    _2
$a farmakoterapie COVID-19 $7 D000093485
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
700    1_
$a Milic, Natasa $u Department of Medical Statistics and Informatics, Faculty of Medicine, University of Belgrade, Belgrade, Serbia
700    1_
$a Chatzikonstantinou, Thomas $u Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece $u Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece
700    1_
$a Scarfò, Lydia $u Università Vita-Salute San Raffaele and IRCC Ospedale San Raffaele, Milan, Italy
700    1_
$a Otasevic, Vladimir $u Lymphoma Center, Clinic for Hematology, University Clinical Center of Serbia, Belgrade, Serbia
700    1_
$a Rajovic, Nina $u Department of Medical Statistics and Informatics, Faculty of Medicine, University of Belgrade, Belgrade, Serbia
700    1_
$a Allsup, David $u Centre for Atherothrombosis and Metabolic Disease, Hull York Medical School, Hull, UK
700    1_
$a Alonso Cabrero, Alejandro $u Haematology Department, Hospital Universitario de La Princesa, Madrid, Spain
700    1_
$a Andres, Martin $u Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
700    1_
$a Baile Gonzales, Monica $u Hematology Department, University Hospital of Salamanca-IBSAL, Salamanca, Spain
700    1_
$a Capasso, Antonella $u IRCSS Ospedale San Raffaele, Milan, Italy
700    1_
$a Collado, Rosa $u Department of Hematology, Hospital General Universitario, Valencia, Spain $u Fundación de Investigación del Hospital General Universitario, Valencia, Spain
700    1_
$a Cordoba, Raul $u Department of Hematology, Health Research Institute IIS-FJD, Fundacion Jimenez Diaz University Hospital, Madrid, Spain
700    1_
$a Cuéllar-García, Carolina $u Hematology Unit Terrassa Hospital, Terrassa, Spain
700    1_
$a Correa, Juan Gonzalo $u Hospital Clínic de Barcelona, Barcelona, Spain
700    1_
$a De Paoli, Lorenzo $u Division of Internal Medicine, Hematology Unit, ASL Vercelli, Vercelli, Italy
700    1_
$a De Paolis, Maria Rosaria $u UOC Ematologia PO Vito Fazzi Lecce, Lecce, Italy
700    1_
$a Del Poeta, Giovanni $u Department of Biomedicine and Prevention Hematology, University Tor Vergata, Rome, Italy
700    1_
$a Dimou, Maria $u 1st Internal Medicine Department, Propaedeutic, Hematology Clinical Trial Unit, National and Kapodistrian University of Athens, Athens, Greece
700    1_
$a Doubek, Michael $u Department of Internal Medicine - Hematology and Oncology, University Hospital, Brno, Czechia $u Department of Medical Genetics and Genomics, Faculty of Medicine, Masaryk University, Brno, Czechia
700    1_
$a Efstathopoulou, Maria $u Department of Haematology Athens Medical Center-Psychikon Branch, Athens, Greece
700    1_
$a El-Ashwah, Shaimaa $u Clinical Hematology Unit, Oncology Center, Faculty of Medicine, Mansoura University, Mansoura, 35516, Egypt
700    1_
$a Enrico, Alicia $u Hospital Italiano La Plata, La Plata, Argentina
700    1_
$a Espinet, Blanca $u Department of Hematology, Hospital del Mar, Barcelona, Spain
700    1_
$a Farina, Lucia $u Hematology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
700    1_
$a Ferrari, Angela $u Hematology Unit, Azienda Unità Sanitaria Locale - IRCCS, Reggio Emilia, Italy
700    1_
$a Foglietta, Myriam $u SC Ematologia, AO S. Croce e Carle, Cuneo, Italy
700    1_
$a Lopez-Garcia, Alberto $u Department of Hematology, Health Research Institute IIS-FJD, Fundacion Jimenez Diaz University Hospital, Madrid, Spain
700    1_
$a García-Marco, José A $u Hematology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain
700    1_
$a García-Serra, Rocío $u Department of Hematology, Hospital General Universitario, Valencia, Spain $u Fundación de Investigación del Hospital General Universitario, Valencia, Spain
700    1_
$a Gentile, Massimo $u Hematology Unit AO Cosenza, Cosenza, Italy
700    1_
$a Gimeno, Eva $u Department of Hematology, Hospital del Mar, Barcelona, Spain
700    1_
$a da Silva, Maria Gomes $u Hematology Department, Portuguese Institute of Oncology Lisbon, Lisbon, Portugal
700    1_
$a Gutwein, Odit $u Department of Hematology, Shamir Medical Center, Zerifin, Israel $u Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
700    1_
$a Hakobyan, Yervand K $u Hematology Center after Prof. Yeolyan MH RA, Yerevan, Armenia
700    1_
$a Herishanu, Yair $u Department of Hematology, Tel Aviv Sourasky Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
700    1_
$a Hernández-Rivas, José Ángel $u Department of Hematology, Infanta Leonor University Hospital, Madrid, Spain
700    1_
$a Herold, Tobias $u Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
700    1_
$a Itchaki, Gilad $u Division of Hematology, Rabin Medical Center, Petah Tikva, and the Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel
700    1_
$a Jaksic, Ozren $u Department of Hematology, University Hospital Dubrava, Zagreb, Croatia
700    1_
$a Janssens, Ann $u Department of Hematology, Universitaire Ziekenhuizen Leuven, Leuven, Belgium
700    1_
$a Kalashnikova, Olga B $u Federal State Budgetary Educational Institution of Higher Education Academician I.P. Pavlov, First St. Petersburg State Medical University of the Ministry of Healthcare of Russian Federation, St. Petersburg, Russia
700    1_
$a Kalicińska, Elżbieta $u Department and Clinic of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Pasteura Street 4, 50-367, Wrocław, Poland
700    1_
$a Kater, Arnon P $u Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands
700    1_
$a Kersting, Sabina $u Department of Hematology, Haga Teaching Hospital, The Hague, The Netherlands
700    1_
$a Koren-Michowitz, Maya $u Department of Hematology, Shamir Medical Center, Zerifin, Israel $u Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
700    1_
$a Labrador, Jorge $u Hematology Department, Unit Research, Complejo Asistencial Universitario de Burgos, Burgos, Spain
700    1_
$a Lad, Deepesh $u Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India
700    1_
$a Laurenti, Luca $u Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore, Rome, Italy $u Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
700    1_
$a Fresa, Alberto $u Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore, Rome, Italy $u Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
700    1_
$a Levin, Mark-David $u Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands
700    1_
$a Mayor Bastida, Carlota $u Haematology Department, Hospital Universitario de La Princesa, Madrid, Spain $u Spanish Society of Haematology and Hemotherapy (SEHH: Sociedad Española de Hematología y Hemoterapia), Madrid, Spain
700    1_
$a Malerba, Lara $u Hematology and Stem Cell Transplant Center Marche Nord Hospital, Pesaro, Italy
700    1_
$a Marasca, Roberto $u Section of Hematology, Department of Medical Sciences, University of Modena and Reggio E., Modena, Italy
700    1_
$a Marchetti, Monia $u Hematology Unit & TMO Center, AO SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
700    1_
$a Marquet, Juan $u Hematology Department, Ramón y Cajal University Hospital, Madrid, Spain
700    1_
$a Mihaljevic, Biljana $u Lymphoma Center, Clinic for Hematology, University Clinical Center of Serbia, Belgrade, Serbia $u Faculty of Medicine, University of Belgrade, Belgrade, Serbia
700    1_
$a Milosevic, Ivana $u Clinical Centre of Vojvodina, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
700    1_
$a Mirás, Fatima $u Hematology Department, Hospital Universitario 12de Octubre, Madrid, Spain
700    1_
$a Morawska, Marta $u Experimental Hematooncology Department, Medical University of Lublin, Lublin, Poland $u Hematology Department, St. John's Cancer Center, Lublin, Poland
700    1_
$a Motta, Marina $u S.C. Ematologia ASST Spedali Civili Brescia, Brescia, Italy
700    1_
$a Munir, Talha $u Consultant Haematologist, St James's Hospital, Leeds, LS9 7TF, UK
700    1_
$a Murru, Roberta $u Hematology and Stem Cell Transplantation Unit, Ospedale Oncologico A. Businco, ARNAS "G. Brotzu", Cagliari, Italy
700    1_
$a Nunes, Raquel $u Hematology Department, Portuguese Institute of Oncology Lisbon, Lisbon, Portugal
700    1_
$a Olivieri, Jacopo $u Hematology Clinic, ASUFC, Udine, Italy
700    1_
$a Pavlovsky, Miguel Arturo $u FUNDALEU, Clinical Research Center Buenos Aires, Buenos Aires, Argentina
700    1_
$a Piskunova, Inga $u Consultative Hematology Department with a Day Hospital for Intensive High-Dose Chemotherapy, National Research Center for Hematology, Moscow, Russia
700    1_
$a Popov, Viola Maria $u Hematology Department, Colentina Clinical Hospital, Bucharest, Romania
700    1_
$a Quaglia, Francesca Maria $u Department of Medicine, Section of Hematology, University of Verona, Verona, Italy
700    1_
$a Quaresmini, Giulia $u Hematology, ASST Papa Giovanni XXIII, Bergamo, Italy
700    1_
$a Reda, Gianluigi $u Hematology Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico of Milan, Milan, Italy
700    1_
$a Rigolin, Gian Matteo $u St. Anna University Hospital, Ferrara, Italy
700    1_
$a Shrestha, Amit $u Hematology Unit, Nepal Cancer Hospital and Research Center, Lalitpur, Nepal
700    1_
$a Šimkovič, Martin $u 4th Department of Internal Medicine - Haematology, Faculty of Medicine in Hradec Králové, University Hospital and Charles University in Prague, Hradec Kralove, Czech Republic
700    1_
$a Smirnova, Svetlana $u Consultative Hematology Department with a Day Hospital for Intensive High-Dose Chemotherapy, National Research Center for Hematology, Moscow, Russia
700    1_
$a Špaček, Martin $u 1st Department of Medicine - Hematology, First Faculty of Medicine, Charles University and General Hospital in Prague, Prague, Czech Republic
700    1_
$a Sportoletti, Paolo $u Department of Medicine and Surgery, Institute of Hematology and Center for Hemato-Oncological Research, Ospedale S. Maria della Misericordia, Perugia, Italy
700    1_
$a Stanca, Oana $u Hematology Department from Coltea Clinical Hospital, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania
700    1_
$a Stavroyianni, Niki $u Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece
700    1_
$a Te Raa, Doreen $u Department of Hematology, Gelderse Vallei Ede, Ede, The Netherlands
700    1_
$a Tomic, Kristina $u Lymphoma Center, Clinic for Hematology, University Clinical Center of Serbia, Belgrade, Serbia
700    1_
$a Tonino, Sanne $u Department of Hematology, Lymmcare, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands
700    1_
$a Trentin, Livio $u Hematology and Clinical Immunology Unit, Department of Medicine, University of Padova, Padua, Italy
700    1_
$a Van Der Spek, Ellen $u Department of Internal Medicine, Rijnstate Hospital, Arnhem, The Netherlands
700    1_
$a van Gelder, Michel $u Department Internal Medicine, Maastricht University Medical Center, Maastricht, The Netherlands
700    1_
$a Varettoni, Marzia $u Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
700    1_
$a Visentin, Andrea $u Hematology and Clinical Immunology Unit, Department of Medicine, University of Padova, Padua, Italy
700    1_
$a Vitale, Candida $u Division of Hematology, A.O.U. Cittàdella Salute e della Scienza di Torino and Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy
700    1_
$a Vukovic, Vojin $u Lymphoma Center, Clinic for Hematology, University Clinical Center of Serbia, Belgrade, Serbia
700    1_
$a Wasik-Szczepanek, Ewa $u Department Hematooncology and Bone Marrow Transplantation, Medical University in Lublin, Lublin, Poland
700    1_
$a Wróbel, Tomasz $u Department and Clinic of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Pasteura Street 4, 50-367, Wrocław, Poland
700    1_
$a Segundo, Lucrecia Yáñez San $u University Hospital and Research Institute of Marqués de Valdecilla (IDIVAL), Santander, Spain
700    1_
$a Yassin, Mohamed $u Hematology Section, Department of Medical Oncology, National Center for Cancer Care and Research, Doha, Qatar
700    1_
$a Coscia, Marta $u Division of Hematology, A.O.U. Cittàdella Salute e della Scienza di Torino and Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy
700    1_
$a Rambaldi, Alessandro $u Hematology, ASST Papa Giovanni XXIII, Bergamo, Italy
700    1_
$a Montserrat, Emili $u Hospital Clínic de Barcelona, Barcelona, Spain
700    1_
$a Foà, Robin $u Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy
700    1_
$a Cuneo, Antonio $u St. Anna University Hospital, Ferrara, Italy
700    1_
$a Carrier, Marc $u Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, K1H 8L6, Canada
700    1_
$a Ghia, Paolo $u Università Vita-Salute San Raffaele and IRCC Ospedale San Raffaele, Milan, Italy
700    1_
$a Stamatopoulos, Kostas $u Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece
773    0_
$w MED00165458 $t Journal of hematology & oncology $x 1756-8722 $g Roč. 15, č. 1 (2022), s. 116
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36028857 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20221017 $b ABA008
991    __
$a 20221031100118 $b ABA008
999    __
$a ok $b bmc $g 1854461 $s 1176024
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 15 $c 1 $d 116 $e 20220826 $i 1756-8722 $m Journal of hematology & oncology $n J Hematol Oncol $x MED00165458
LZP    __
$a Pubmed-20221017

Najít záznam

Citační ukazatele

Možnosti archivace